166 related articles for article (PubMed ID: 33825059)
61. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
62. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
[TBL] [Abstract][Full Text] [Related]
63. Radiofrequency ablation of hepatic metastases after curative resection of extrahepatic cholangiocarcinoma.
Park SY; Kim JH; Won HJ; Shin YM; Kim PN
AJR Am J Roentgenol; 2011 Dec; 197(6):W1129-34. PubMed ID: 22109330
[TBL] [Abstract][Full Text] [Related]
64. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
65. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
[TBL] [Abstract][Full Text] [Related]
66. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
[TBL] [Abstract][Full Text] [Related]
67. HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial.
Yang T; Ng DM; Du N; He N; Dai X; Chen P; Wu F; Chen B; Fan X; Yan K; Zhou X; Dong M; Zheng Z; Gu L
Surg Endosc; 2021 May; 35(5):2306-2315. PubMed ID: 32435962
[TBL] [Abstract][Full Text] [Related]
68. Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.
Navarra G; Ayav A; Weber JC; Jensen SL; Smadga C; Nicholls JP; Habib NA; Jiao LR
Int J Colorectal Dis; 2005 Nov; 20(6):521-8. PubMed ID: 15864606
[TBL] [Abstract][Full Text] [Related]
69. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation.
Vietti Violi N; Duran R; Demartines N; Sempoux C; Guiu B; Bize PE; Sala N; Halkic N; Knebel JF; Denys A
Int J Hyperthermia; 2018 Nov; 34(7):1020-1028. PubMed ID: 29506424
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
[TBL] [Abstract][Full Text] [Related]
71. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.
Facciorusso A; Del Prete V; Muscatiello N; Crucinio N; Barone M
J Gastroenterol Hepatol; 2016 Aug; 31(8):1483-8. PubMed ID: 26896637
[TBL] [Abstract][Full Text] [Related]
72. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
73. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
[TBL] [Abstract][Full Text] [Related]
74. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
[TBL] [Abstract][Full Text] [Related]
75. Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
Shi F; Wu M; Lian SS; Mo ZQ; Gou Q; Xu RD; Li HL; Huang ZM; Wu PH; Chen XM
Radiology; 2019 Dec; 293(3):707-715. PubMed ID: 31638492
[TBL] [Abstract][Full Text] [Related]
76. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
Abitabile P; Hartl U; Lange J; Maurer CA
Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
[TBL] [Abstract][Full Text] [Related]
77. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
78. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma.
Pan C; Wu P; Yu J; Li W; Huang Z; He N; Wang J; Zhao M
Int J Hyperthermia; 2011; 27(6):549-54. PubMed ID: 21846191
[TBL] [Abstract][Full Text] [Related]
79. Comparison study of computed tomography-guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case-controlled observational study.
Chi J; Ding M; Shi Y; Wang T; Cui D; Tang X; Li P; Zhai B
Thorac Cancer; 2018 Oct; 9(10):1241-1248. PubMed ID: 30070054
[TBL] [Abstract][Full Text] [Related]
80. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
